Bank of America Reiterates Buy on Vertex Pharmaceuticals, Raises Price Target to $245

Bank of America reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $235 to $245.

Benzinga · 11/20/2019 16:27

Bank of America reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $235 to $245.